Hepatitis C virus (HCV) is a leading cause of liver chronic diseases all over the world; in developed countries the highest prevalence of infection is reported among intravenous drug users and hemodialysis patients. Lanini, et al. (2010) sought to identify the pathway of HCV transmission during an outbreak of HCV infection in a privately run hemodialysis unit in Italy in 2005. Their research was published in BMC Infectious Diseases.
Dynamics of the outbreak and infection clinical outcomes were defined through an ambi-directional cohort study. Molecular epidemiology techniques were used to define the relationships between the viral variants infecting the patients and confirm the outbreak. Risk analysis and auditing procedures were carried out to define the transmission pathways.
The researchers report that of the 50 patients treated in the hemodialysis unit, five were already anti-HCV positive and 13 became positive during the study period (AR= 28.9 percent). Phylogenic analysis identified that, all the molecularly characterized incident cases (10 out of 13), were infected with the same viral variant of one of the prevalent cases. The multivariate analysis and the auditing procedure disclosed a single event of multi-dose vials heparin contamination as the cause of transmission of the infection in 11 out of the 13 incident cases; two additional incident cases occurred possibly as a result of inappropriate risk management.
Lanini, et al. (2010) say that more than 30 percent of all HCV infections in developed countries results from poor application of standard precautions during percutaneous procedures. They add that a comprehensive strategy that includes educational programs, periodical auditing on standard precaution, use of single-dose vials whenever possible, prospective surveillance for bloodborne infections (including a system of prompt notification) and risk assessment/management dedicated staff is the cornerstone to contain and prevent outbreaks in hemodialysis units.
The researchers conclude that patients undergoing dialysis are at risk for HCV infection and that HCV may be easily transmitted whenever standard precautions are not strictly applied.
Reference: Lanini S, Abbate I, Puro V, Soscia F, Albertoni F, Battisti W, Ruta A, Capobianchi MR and Ippolito G. Molecular epidemiology of a hepatitis C virus epidemic in a haemodialysis unit: outbreak investigation and infection outcome. BMC Infectious Diseases 2010, 10:257doi:10.1186/1471-2334-10-257
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
From Pandemic to Endemic: How the Protective Face Mask Market Is Evolving
August 2nd 2025Once a symbol of crisis, face masks have evolved into everyday essentials—driven not only by pandemic preparedness but by rising air pollution, cultural shifts, and workplace safety regulations. As innovation and demand grow worldwide, the protective face mask market is poised for long-term expansion well beyond COVID-19.
Is the US Quietly Ending COVID-19 Vaccination for the Young and Healthy
August 2nd 2025As the FDA limits COVID-19 vaccine approvals to high-risk groups, healthy adults and pregnant individuals are being left behind. Learn how these changes could impact insurance coverage, long COVID prevention, and public health strategies.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
August 2nd 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
August 2nd 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.